Merck, a leading science and technology company, has announced the broadening of its manufacturing footprint with a comb...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration ...
BioNTech SE and Pfizer Inc. on 30 Nov 2020 have submitted a formal Application for Conditional Marketing ...
Three members of the COVID R&D Alliance - Amgen Inc, Takeda Pharmaceutical Co Ltd and UCB announced the fi...
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vacci...
The World Health Organization coordinated its latest cargo donation through DHL Global Forwarding (DHL), the freight spe...
The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...
To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...
Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...
Nearly six months after the first cases were reported in Equateur Province, the 11th Ebola outbreak in the Democratic Re...
PerkinElmer, Inc., on 16 Nov 2020 introduced the LC 300TM platform and SimplicityChromTM softwa...
This World Diabetes Day, the International Diabetes Federation (IDF) is calling for more nurses to be trained to help pe...
Medtronic plc has announced the launch of InPen™ integrated with real-time Guardian Connect™ CGM data. InPen...
QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by labora...
PerkinElmer, Inc. has launched its newest ChemDraw® application, ChemOffice®+ Cloud, to simplify, faci...
PerkinElmer, Inc., announced on 9 Oct 2020 that EUROIMMUN, a PerkinElmer company, has launched the Anti-S...
Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...
